Bangladeshi Moin's successful startup dreams in Canada

মোহাম্মদ মঈন, সিইও, সোমরু বায়োসায়েন্স
মোহাম্মদ মঈন, সিইও, সোমরু বায়োসায়েন্স

The time is 2000. Mohammad Moin, a boy from Shyamnagar village of Sunamganj, was preparing to go abroad for higher education after completing his studies at Sylhet Cadet College. At that time, Shamsul Islam's father, a school teacher, was diagnosed with cancer. But at that time, the necessary medicine for cancer was not available in the country. Whatever he was getting, the prices were beyond his reach. Moeen's father died after six months of treatment in such a reality.

His father's death from cancer changed Moin's life. So that no one else has to suffer like Moin's father, he went to Canada and established Somru Bioscience Company, a technology-based startup for making medicine. The main objective of this organization is to provide technical services to reduce the time and cost of manufacturing life saving medicines.

কানাডার আটলান্টিক প্রদেশে বর্ষসেরা আর্নেস্ট অ্যান্ড ইয়াং এন্ট্রাপ্রেনিউরস অব দ্য ইয়ার পুরস্কার হাতে স্ত্রী দিহান আহসানের সঙ্গে উদ্যোক্তা মোহাম্মদ মঈন। ২০১৮ সালে মঈন এ পুরস্কার পান।
কানাডার আটলান্টিক প্রদেশে বর্ষসেরা আর্নেস্ট অ্যান্ড ইয়াং এন্ট্রাপ্রেনিউরস অব দ্য ইয়ার পুরস্কার হাতে স্ত্রী দিহান আহসানের সঙ্গে উদ্যোক্তা মোহাম্মদ মঈন। ২০১৮ সালে মঈন এ পুরস্কার পান।

Recently, Mohammad Moin came to the country from Canada on a short visit. Prothom Alo talked about his startup and entrepreneurship in foreign countries. At that time, Moin said, when my father was sick, I had no idea about cancer healthcare. The elder brother then worked in a pharmaceutical manufacturing laboratory in the United States. Most of the medicines he mentioned for my father were not available in the country. Those that were available were also very expensive. That's when I decided to work on how to make medicines that save people's lives more easily and at affordable prices.

Mohammad Moin was interested in studying computer science since his childhood. From that interest, he went to study computer science and bioinformatics at Trent University in Ontario, Canada in 2001. Along with studies, he was thinking of a job. But there were very limited part-time job opportunities for foreign students in the country at that time. For this reason, in the second year, he moved to Prince Edward Island University in the eastern part of Canada.

Worked as an intern in various technology companies in third and fourth year. While in the fourth year, Dihan got married to Ahsan. After marriage, the two lived together in a rented room on the ground floor of a house in Prince Edward Island. In 2007, Moin started his career in medicine information management in a technology company. Joined another technology company in 2012. And the journey of his Somru Bioscience Company started that year.

Moeen's elder brother Rafiqul Islam then worked on drug quality control projects for leading US drug companies Amgen and Covance (now Labcorp Drug Development). The elder brother had experience in making medicine, and Moin had technical skills. So Moin thought, two brothers can start something new together.

This Bangladeshi entrepreneur from Canada said that it usually takes about 10 years to bring a drug to the market after going through the various stages of making biological drugs. The price of these drugs is very high. Biosimilar medicines provide some relief in this case. Any company can make copies of patented or copyrighted biological drugs. These are called biosimilar drugs. Only the copycat company can market such drugs after the intellectual property expires. It is possible to bring the medicine in the market in less time and at affordable price. So Moin and his brother started working with biosimilar drugs.

Moeen's school teacher father was known as 'Somru Master' in Sylhet. So he registered Somru Bioscience Company in his name in 2012. They started the journey of the startup company with an investment of only one hundred thousand US dollars. Early on he was allocated a place at the National Research Council's National Research Council Incubation Center in Canada. Later, in 2014, he set up a laboratory at his own place.

কানাডায় সোমরু কার্যালয় পরিদর্শন করছেন দেশটির ফেডারেল সরকারের মন্ত্রী পেটিটপাস টেলর ও স্থানীয় সংসদ সদস্য শন ক্যাসি।
কানাডায় সোমরু কার্যালয় পরিদর্শন করছেন দেশটির ফেডারেল সরকারের মন্ত্রী পেটিটপাস টেলর ও স্থানীয় সংসদ সদস্য শন ক্যাসি।

At present, more than half a hundred experts and staff work in Somru Bioscience of Moin. Along with the two brothers, Moin's wife Dihan Ahsan and sister-in-law Clarinda Islam are involved in the management of the company.

Somru has received 1 crore 85 million US dollars in investment and financial support from the federal and state governments of Canada so far. The institute mainly provides technical support in various stages of manufacturing of biological drugs. Such as testing the type of drugs, arranging global clinical trials, analyzing data, verifying the safety and efficacy of drugs, obtaining the approval of the United States Food and Drug Administration (FDA) and the European Union (EU) drug regulatory agency European Medicines Agency (EMA), arranging for drug marketing permission, etc. Apart from this, the company also provides kit and biomaker detection (verification of how drugs work in the body) services. The main market for the company's products and services is the United States, followed by Europe.

In addition, Somru set up a laboratory in Ahmedabad, Gujarat, India in 2021. They are going to set up a second laboratory in Bangalore this year. Currently, Somru is working with more than 100 companies in 23 countries of the world with 112 types of medicines.

২০১৯ সালে কানাডার বিশিষ্ট উদ্ভাবক ও গবেষক ডাফের সঙ্গে সিন্যাপস ইন্সপায়ারিং ইয়াং ইনোভেটর পুরস্কার বিজয়ী মোহাম্মদ মঈন
২০১৯ সালে কানাডার বিশিষ্ট উদ্ভাবক ও গবেষক ডাফের সঙ্গে সিন্যাপস ইন্সপায়ারিং ইয়াং ইনোভেটর পুরস্কার বিজয়ী মোহাম্মদ মঈন

Moin said that there is a good possibility of developing biosimilar medicines in Bangladesh. If this is done, it will be possible to export such drugs from the country besides meeting the local demand. Somru received an award from the Federal Government of Canada in recognition of his work.

This startup company wants to establish itself as the world's top biosimilar technology supplier in the future. Besides, in the future, they are proceeding with the plan to produce new biological drugs. Somru is already working on five types of cancer drugs. Apart from this, Somru Foundation has been established in Sylhet to improve the quality of education and healthcare for underprivileged people.

Moin said, 'Father's death was a message for me. It is my wish that common people can buy life-saving medicines at low prices.

🌐 This English version was automatically translated from the original Bangla.

Original reporting: Voice of Startup Bangladesh

← All news